GAS6 and cirrhosis of liver: These methods were used by Holstein and colleagues from German Cancer Research Center (DKFZ) to show HSC activation by TGF-β and Growth Arrest-Specific 6 (GAS6) (human growth inhibitor-specific 6)/AXL pathways in liver cirrhosis and cancer.